CORPORATE OVERVIEW April 2025 MARINE PRODUCTS CORPORATION FORWARD LOOKING STATEMENTS NON-GAAP DISCLOSURE Certain statements and information included in this press release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements that look forward in time or express management's beliefs, expectations, hopes or strategies. In particular, such statements include, without limitation: our plans to begin ...

Core Insights - Boston Scientific (BSX) has raised its full-year 2025 guidance for net sales growth to approximately 15-17% on a reported basis and nearly 12-14% on an organic basis, reflecting strong first-quarter results and ongoing momentum in key growth areas [1][8] - The company reported an organic sales growth of 18% in the first quarter, exceeding the guided range of 14-16%, with adjusted EPS at $0.75, a 34% year-over-year increase [2] - The Cardiology segment saw a significant sales increase of 31%, driven by products like WATCHMAN and AGENT drug-coated balloon, while the Electrophysiology business experienced a remarkable 145% year-over-year growth [3][8] Financial Performance - Full-year adjusted earnings per share are now expected to be in the range of $2.87-$2.94, up from the previous estimate of $2.80-$2.87 [1] - The company anticipates a $200 million tariff impact in 2025, primarily in the second half, but plans to offset this through organic sales growth and discretionary spending reductions [4] Competitive Landscape - Competitors like Edwards Lifesciences and Stryker have also adjusted their sales forecasts, with Edwards maintaining an 8-10% growth forecast and Stryker raising its guidance to 8.5-9.5% organic growth [5][6] - Boston Scientific's stock has outperformed the industry, gaining 33.4% over the past year compared to the industry's 8.8% growth [7] Valuation Metrics - Boston Scientific currently trades at a forward 12-month price-to-earnings ratio of 33.19X, which is above the industry average of 20.83X [9]

23 June 2025 | 5:00AM EDT Americas Transportation: US Tariff Impact Tracker - High Frequency Trends Potentially Reveal Ebbing in China Surge US Tariff Impact Tracker – The directional uptick in inbound traffic from China to the US ebbed last week and in fact showed slight sequential downticks of -7% for vessels and -4% for TEU's, perhaps indicative that the China surge may be somewhat abbreviated or have less depth than some may have previously thought. That said, based on other data it is possible another ...

June 22, 2025 09:01 PM GMT Asia – Apparel and Footwear Supply Chain | Asia Pacific Managing Uncertainties – Tariff Impact Scenario Analysis What's Changed | Makalot Industrial (1477.TW) | From | To | | --- | --- | --- | | Price Target | NT$310.00 | NT$250.00 | | Eclat Textile (1476.TW) | | | | Price Target | NT$640.00 | NT$550.00 | | Feng Tay (9910.TW) | | | | Price Target | NT$168.00 | NT$145.00 | | Lai Yih Footwear Co Ltd (6890.TW) | | | | Price Target | NT$320.00 | NT$270.00 | | Rating | Equal-weight | U ...

Equity Strategy Rie Nishihara AC (81-3) 6736-8629 rie.nishihara@jpmorgan.com J P M O R G A N Global Markets Strategy 20 June 2025 Japan Equity Strategy Direction of Japan-US tariff negotiations after G7 summit and impact of Section 899 Japanese and US tariff negotiators did not reach an agreement during the G7 meeting in Canada. However, negotiations appear to be moving forward and are not at a complete standstill, perhaps reflecting a strategic aspect of refraining from producing clear results before Japan ...

Global Commodities Research 13 June 2025 J P M O R G A N Global Commodities The Week in Commodities At Any Rate: Aluminum's premium paralysis Global Commodities Research Natasha Kaneva (1-212) 834-3175 natasha.kaneva@jpmorgan.com JPMorgan Chase Bank NA Tracey Allen (44-20) 7134-6732 tracey.l.allen@jpmorgan.com J.P. Morgan Securities plc This is a summary note that consolidates the latest views of our global commodity strategists published over the week; to read detailed reports, refer to the hyperlinks. It ...

In the morning of 11 Jun Mexico local time, Hengli hosted an opening ceremony at its Mexico plant, Monterrey, Mexico state of Nuevo León. Following the ceremony, Hengli will commence the production of the Mexico plant this month, starting with the excavator components for US clients. Mgmt. guided that the revenue of the Mexico plant targets could reach Rmb200mn-300mn in 2025, representing only 2%-3% of our 2025E revenue forecast. Although the sales and earnings contribution from the Mexico factory is limite ...

12 June 2025 | 9:22AM EDT US Daily: A Slightly Smaller Tariff Effect (Mericle) Jan Hatzius +1(212)902-0394 | jan.hatzius@gs.com Goldman Sachs & Co. LLC Alec Phillips +1(202)637-3746 | alec.phillips@gs.com Goldman Sachs & Co. LLC David Mericle +1(212)357-2619 | david.mericle@gs.com Goldman Sachs & Co. LLC Ronnie Walker +1(917)343-4543 | ronnie.walker@gs.com Goldman Sachs & Co. LLC Manuel Abecasis +1(212)902-8357 | manuel.abecasis@gs.com Goldman Sachs & Co. LLC Elsie Peng +1(212)357-3137 | elsie.peng@gs.com G ...

Core Viewpoint - Victoria's Secret & Co. has faced challenges in its financial outlook, leading to lowered earnings guidance and cautious analyst sentiment regarding its performance in a competitive market [1][4]. Financial Performance - The company reported first-quarter adjusted earnings per share of 9 cents, aligning with analyst consensus estimates [1]. - Quarterly sales reached $1.35 billion, remaining flat year over year and also meeting market expectations [1]. Fiscal Year Guidance - Victoria's Secret has revised its fiscal year 2025 adjusted operating income guidance to a range of $270 million to $320 million, down from a previous forecast of $300 million to $350 million [2]. - For the second quarter, the company forecasts sales between $1.38 billion and $1.41 billion, slightly below the $1.42 billion estimate [3]. Profitability Concerns - The analyst noted that profit forecasts for the second quarter lagged behind prior consensus, which had already accounted for a $10 million impact from cybersecurity issues and another $10 million from tariffs [3]. - A gross tariff impact of $120 million is expected for the year, with $70 million already mitigated, resulting in a net hit of $50 million that could reduce gross margin by over 100 basis points [6]. Strategic Adjustments - The company has taken steps to mitigate tariff impacts, including cost-cutting measures, diversifying sourcing, and improving shipping efficiency [7]. - Victoria's Secret is shifting from blanket discounts to more targeted promotions, such as gift-with-purchase events [7]. Earnings Projections - The analyst has lowered the fiscal year 2025 EPS estimate to $2.10 from $2.22, and for fiscal year 2026, the EPS is now projected at $2.25, down from $2.38 [7][8].

根据 Counterpoint Research最新的《全球智能手机制造分布追踪报告》 ，受关税影响及行业整体发 展放缓的冲击，2025年全球智能手机制造产量预计将同比下降1%，相较于2024年产量4%的同比增 长，不难看出市场情况不容乐观。2024年，中国、印度和越南共持有全球智能手机总产量的90%以 上，其中印度增速最快。但是各国制造产量在2025年预计呈现分化态势。 数据来源： Counterpoint Research 《全球智能手机制造分布追踪报告》 2025年全球智能手机制造产量预计会减少1%，主要受关税影响和行业整体发展放缓的冲击。 中国将感受到明显的关税影响，导致智能手机整机制造产量下滑和国内市场表现不佳。 印度有望成为最大受益者，Apple和Samsung持续的出口需求预计能推动产量以两位数百分比 增长，制造份额首次突破全球总产量的20%。 越南作为全球制造与出口枢纽，产量预计也能实现稳健增长，在Samsung和Motorola受关税压 力和制造转移的影响下增产而受惠。 其他地区主要受本地市场影响。在全球智能手机需求受限的情况下，这些原本占比就低的市场 也可能会面对一定的下滑压力。 分析师观 ...